How Long Ozempic Stays in Your System
Ozempic (semaglutide) has an elimination half-life of approximately 7 days (1 week), meaning it remains in your circulation for about 5 weeks after the last dose. 1
Pharmacokinetic Timeline
Half-Life and Elimination
- Semaglutide has a half-life of approximately 7 days, which is what allows for once-weekly dosing 1, 2
- The drug will be present in the circulation for approximately 5 weeks (about 35 days) after your last dose 1
- This extended presence is due to the drug's extensive binding to plasma albumin (>99%) and slow clearance rate 1
Time to Steady State
- Steady-state exposure is achieved after 4-5 weeks of once-weekly administration 1, 2
- This means it takes about a month of regular weekly injections for the drug to reach consistent levels in your system 1
Absorption and Peak Concentration
- Maximum concentration is reached 1-3 days after each injection 1
- The absolute bioavailability is 89% when administered subcutaneously 1
Metabolism and Excretion
How the Body Processes Semaglutide
- The primary elimination route is through metabolism via proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid side chain 1
- The apparent clearance in patients with type 2 diabetes is approximately 0.05 L/h, which is quite slow 1
Excretion Pathways
- Only approximately 3% of the dose is excreted in urine as intact semaglutide 1
- The remainder is excreted as metabolites via both urine and feces 1
Clinical Implications of Extended Duration
Weight Regain After Stopping
- Significant weight regain occurs after discontinuation, with patients regaining 11.6% of lost weight over 52 weeks after stopping treatment 3
- In one trial, patients who transitioned to placebo after 20 weeks of treatment regained 6.9% of lost weight during 48 weeks of placebo administration 3
- This underscores that semaglutide requires long-term, potentially lifelong use to maintain weight loss benefits 3
Factors That Don't Affect Duration
- Age, sex, race, ethnicity, and renal impairment do not have clinically meaningful effects on semaglutide pharmacokinetics 1
- Hepatic impairment does not impact semaglutide exposure 1
- Body weight affects exposure (higher weight = lower exposure), but the standard doses provide adequate coverage across the weight range of 40-198 kg 1
Important Caveats
Drug Interactions
- The delay in gastric emptying caused by semaglutide may influence absorption of oral medications, though clinical studies showed no clinically relevant interactions with commonly co-administered drugs (metformin, oral contraceptives, warfarin, digoxin, atorvastatin) 1
- Semaglutide has very low potential to inhibit or induce CYP enzymes or drug transporters 1
Missed Doses
- If you miss 2 consecutive doses, you can resume at the same dose if previously well-tolerated 4
- If you miss 3 or more consecutive doses, consider restarting the full titration schedule 4
The 5-week presence in your system after stopping means that both therapeutic effects and potential side effects may persist for over a month after your last injection, which is crucial for planning any medication changes or surgical procedures.